Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?

Although evidence has accumulated that long-term aspirin therapy is beneficial in secondary prevention of cardiovascular disease (CVD), a lot of controversies persist regarding the benefit of aspirin use in primary prevention of CVD. In low-income countries (LIC) specifically, the decision to prescr...

Descripción completa

Detalles Bibliográficos
Autores principales: Noubiap, Jean Jacques N, Nansseu, Jobert Richie N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556041/
https://www.ncbi.nlm.nih.gov/pubmed/26345154
http://dx.doi.org/10.2147/VHRM.S87398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556041/
https://www.ncbi.nlm.nih.gov/pubmed/26345154
http://dx.doi.org/10.2147/VHRM.S87398

Ejemplares similares